The new cholesterol guidelines: Applying them in clinical practice

Postgraduate Medicine

Volumn 112, Issue 2, 2002, Pages

  Pearlman, Brian L ^a  

^a NONE

Author keywords

[No Author keywords available]

Indexed keywords

CHOLESTEROL; HIGH DENSITY LIPOPROTEIN CHOLESTEROL; LIPID; LOW DENSITY LIPOPROTEIN CHOLESTEROL;

ADULT; CASE REPORT; CHOLESTEROL BLOOD LEVEL; CLINICAL PRACTICE; CORONARY ARTERY DISEASE; DIET THERAPY; EDUCATION PROGRAM; HUMAN; HYPERLIPIDEMIA; LIFESTYLE; MALE; PRACTICE GUIDELINE; REVIEW; RISK ASSESSMENT; RISK FACTOR; SCORING SYSTEM; SMOKING;

EID: 0036674216     PISSN: 00325481     EISSN: None     Source Type: Journal    
DOI: 10.3810/pgm.2002.08.1269     Document Type: Review

References (25)

1. Cholesterol and mortality: 30 years of follow-up from the Framingham study
2. Is relationship between serum cholesterol and risk of premature death from coronary heart disease continuous and graded? Findings in 356,222 primary screenees of the Multiple Risk Factor Intervention Trial (MRFIT)
3. Executive summary of the third report of the National Cholesterol Education Program (NCEP) Expert Panel on Detection, Evaluation, and Treatment of High Blood Cholesterol in Adults (Adult Treatment Panel III)
4. Diabetes and all-cause and coronary heart disease mortality among US male physicians
5. Mortality from coronary heart disease in subjects with type 2 diabetes and in nondiabetic subjects with and without prior myocardial infarction
6. Validation of the Framingham coronary heart disease prediction scores: Results of a multiple ethnic groups investigation
7. Blood levels of long-chain n-3 fatty acids and the risk of sudden death
8. Incremental reduction of serum total cholesterol and low-density lipoprotein cholesterol with the addition of plant stanol ester-containing spread to statin therapy
9. Reduction of serum cholesterol with sitostanolester margarine in a mildly hypercholesterolemic population
10. Cardiovascular morbidity and mortality associated with the metabolic syndrome
11. Prevalence of the metabolic syndrome among US adults: Findings from the third National Health and Nutrition Examination Survey
12. Hypertriglyceridemia as a cardiovascular risk factor
13. Do triglycerides provide meaningful information about heart disease risk?
14. Atherogenicity of triglyceride-rich lipoproteins
15. Non-high-density lipoprotein cholesterol level as a predictor of cardiovascular disease mortality
16. Effects of atorvastatin on early recurrent ischemic events in acute coronary syndromes. The MIRACL study: A randomized controlled trial
17. Improved treatment of coronary heart disease by implementation of a Cardiac Hospitalization Atherosclerosis Mangagement Program (CHAMP)
18. Gemfibrozil for the secondary prevention of coronary heart disease in men with low levels of high-density lipoprotein cholesterol
19. Clarifying the direct relation between total cholesterol levels and death from coronary heart disease in older persons
20. Therapy with hydroxymethylglutaryl coenzyme A reductase inhibitors (statins) and associated risk of incident cardiovascular events in older adults
21. Randomized trial of estrogen plus progestin for secondary prevention of coronary heart disease in postmenopausal women
22. The lipid treatment assessment project (L-TAP)